FDA expected to give first full approval for Alzheimer's drug
Wednesday, for the first time ever, the FDA may give full approval to a drug designed to slow the progression of Alzheimer's disease.
Posted — UpdatedHelp could be on the way for millions of people living with Alzheimer's.
Wednesday, for the first time ever, the U.S. Food and Drug Administration (FDA) may give full approval to a drug designed to slow the progression of the disease.
A clinical trial showed the drug slowed cognitive decline by 27% in patients who were in the early stage of Alzheimer's -- a disease impacting more than 300,000 North Carolinians.
Here's how the drug works
By breaking down the proteins, it slows down the disease.
It's expected to cost around $25,000 dollars a year for treatment, according to the North Carolina Medical Society.
Related Topics
• Credits
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.